scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH)
CUSIP: 810648105
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 53,364,241
- Total 13F shares
- 38,194,973
- Share change
- +697,689
- Total reported value
- $145,545,847
- Put/Call ratio
- 0%
- Price per share
- $3.81
- Number of holders
- 95
- Value change
- +$3,415,856
- Number of buys
- 50
- Number of sells
- 44
Quarterly Holders Quick Answers
What is CUSIP 810648105?
CUSIP 810648105 identifies SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 810648105:
Top shareholders of SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| 5AM Partners IV, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,734,852
|
$17,475,704 | — | 06 Oct 2022 | |
| ORBIMED ADVISORS LLC |
13F
3/4/5
|
Company · 10%+ Owner |
11%
|
6,059,528
|
$15,936,559 | — | 31 Mar 2025 | |
| Rubric Capital Management LP |
13F
|
Company |
8.9%
|
4,775,000
|
$12,558,250 | — | 31 Mar 2025 | |
| AIGH Capital Management LLC |
13F
|
Company |
7.7%
|
4,096,367
|
$10,773,445 | — | 31 Mar 2025 | |
| KING LUTHER CAPITAL MANAGEMENT CORP |
13F
|
Company |
5.8%
|
3,121,170
|
$8,208,677 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
4.4%
|
2,356,812
|
$6,198,417 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.7%
|
1,992,760
|
$5,240,959 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
3.5%
|
1,886,141
|
$4,960,551 | — | 31 Mar 2025 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
2.6%
|
1,398,057
|
$3,676,890 | — | 31 Mar 2025 | |
| 5AM Venture Management, LLC |
13F
|
Company |
2.2%
|
1,200,647
|
$3,157,702 | — | 31 Mar 2025 | |
| THRIVENT FINANCIAL FOR LUTHERANS |
13F
|
Company |
1.9%
|
1,036,716
|
$2,727,000 | — | 31 Mar 2025 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
1.9%
|
1,000,000
|
$2,630,000 | — | 31 Mar 2025 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
1.9%
|
995,438
|
$2,618,002 | — | 31 Mar 2025 | |
| Velan Capital Investment Management LP |
13F
|
Company |
1.7%
|
917,668
|
$2,413,467 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
807,480
|
$2,123,862 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.4%
|
733,742
|
$1,929,741 | — | 31 Mar 2025 | |
| Tejara Capital Ltd |
13F
|
Company |
1.2%
|
662,052
|
$1,741,197 | — | 31 Mar 2025 | |
| J. Goldman & Co LP |
13F
|
Company |
1.1%
|
586,235
|
$1,541,798 | — | 31 Mar 2025 | |
| APIS CAPITAL ADVISORS, LLC |
13F
|
Company |
0.95%
|
504,947
|
$1,328,011 | — | 31 Mar 2025 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.94%
|
500,000
|
$1,315,000 | — | 31 Mar 2025 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
0.65%
|
347,687
|
$914,417 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.61%
|
327,415
|
$861,101 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.6%
|
317,540
|
$835,131 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.23%
|
120,897
|
$317,959 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.2%
|
105,935
|
$278,609 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.17%
|
90,503
|
$238,023 | — | 31 Mar 2025 | |
| Johnson Financial Group, LLC |
13F
|
Company |
0.16%
|
85,184
|
$224,034 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.16%
|
84,390
|
$221,946 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.15%
|
78,147
|
$205,528 | — | 31 Mar 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.14%
|
75,474
|
$198,497 | — | 31 Mar 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.14%
|
75,077
|
$197,452 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.14%
|
73,909
|
$194,381 | — | 31 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.14%
|
73,210
|
$192,543 | — | 31 Mar 2025 | |
| Balanced Rock Investment Advisors LLC |
13F
|
Company |
0.13%
|
71,200
|
$187,256 | — | 31 Mar 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.13%
|
67,900
|
$178,577 | — | 31 Mar 2025 | |
| WEALTHEDGE INVESTMENT ADVISORS, LLC |
13F
|
Company |
0.12%
|
65,047
|
$171,074 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.1%
|
51,716
|
$136,013 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.1%
|
51,499
|
$135,430 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.09%
|
46,613
|
$122,592 | — | 31 Mar 2025 | |
| CAPTRUST FINANCIAL ADVISORS |
13F
|
Company |
0.08%
|
40,125
|
$105,529 | — | 31 Mar 2025 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.07%
|
39,771
|
$105,000 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.07%
|
38,663
|
$101,684 | — | 31 Mar 2025 | |
| COMERICA BANK |
13F
|
Company |
0.07%
|
38,662
|
$101,681 | — | 31 Mar 2025 | |
| Thomasville National Bank |
13F
|
Company |
0.07%
|
37,500
|
$98,625 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.07%
|
36,195
|
$95,192 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.06%
|
31,603
|
$83,116 | — | 31 Mar 2025 | |
| INTECH INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.06%
|
30,311
|
$79,718 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.05%
|
28,835
|
$75,835 | — | 31 Mar 2025 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.05%
|
28,759
|
$75,636 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.05%
|
28,702
|
$75,487 | — | 31 Mar 2025 |
Institutional Holders of scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) as of Q2 2025
As of 30 Jun 2025,
scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) was held by
95 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,194,973 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Rubric Capital Management LP, AIGH Capital Management LLC, KING LUTHER CAPITAL MANAGEMENT CORP, BlackRock, Inc., MORGAN STANLEY, VANGUARD GROUP INC, RICE HALL JAMES & ASSOCIATES, LLC, 5AM Venture Management, LLC, and Nantahala Capital Management, LLC.
This page lists
95
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
87
Q2 2025 holders
95
Holder diff
8
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.